Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Mol Genet Metab. 2013 Jun 26;110(0):129–138. doi: 10.1016/j.ymgme.2013.06.008

Table 4.

KS levels in MPS IVA patients with attenuated and severe phenotypes

Attenuated Urine KS (mg/gCre) Blood KS (ng/ml) Severe Urine KS (mg/gCre) Blood KS (ng/ml)
Over 5 years* Mean 2.4 410.4 Mean 6.7 564.4
SD 4.3 196.9 SD 6.4 359.4
n 21 24 n 43 43

Under 5 years# Mean Mean 11.0 573.9
SD SD 12.7 224.1
n n 20 23

5 to 15 years** Mean 3.5 486.4 Mean 8.6 689.5
SD 5.5 204.7 SD 7.1 349.1
n 12 14 n 28 29

Over 15 years*** Mean 1.0 392.4 Mean 3.0 305.3
SD 1.0 361.7 SD 2.1 217.9
n 9 10 n 15 14
*

Urine KS, P = 0.0029; blood KS, P = 0.0385

**

Urine KS, P = 0.0199; blood KS, P = 0.0196

***

Urine KS, P = 0.6647; P = 0.7614

#

Data for urine KS is not available in the patients with an attenuated phenotype.